Philippe Gabriel Steg News Today : Breaking News, Live Updates & Top Stories | Vimarsana

New Evidence Challenges Widespread Prescription of Beta-Blockers for Heart Attack Patients

New Evidence Challenges Widespread Prescription of Beta-Blockers for Heart Attack Patients
theepochtimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theepochtimes.com Daily Mail and Mail on Sunday newspapers.

France generalUnited statesNew zealandPhilippe gabriel stegTroels yndigegnResearch also questions the cardiac status quoFinds no benefitsNew england journalResearch also questionsCardiac status quoa

REDUCE-IT Lp(a) Analysis Details Icosapent Ethyl Effect on MACE Across Lp(a) Range

A REDUCE-IT analysis highlights consistent cardiovascular benefits with icosapent ethyl across varying levels of Lp(a).

United statesHarpreet bhatiaPhilippe gabriel stegNabil abadirColl cardiolMichael blahaDivision of cardiovascular medicineAmerican heart associationJohns hopkins ciccarone centerResearch evaluatingGlobal medical affairs at amarinInstitute philipe gabriel stegAmerican college of cardiologyUniversity of california san diegoDepartment of cardiologyPhilipe gabriel steg

Research Evaluating Benefits of VASCEPA®/VAZKEPA® (icosapent ethyl) to be Presented at the American College of Cardiology s (ACC) Annual Scientific Session & Expo -March 25, 2024 at 08:00 am EDT

Research Evaluating Benefits of VASCEPA®/VAZKEPA® (icosapent ethyl) to be Presented at the American College of Cardiology s (ACC) Annual Scientific Session & Expo -March 25, 2024 at 08:00 am EDT
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United statesNew jerseyUnited arab emiratesBrady parkUnited kingdomGreat britainEhab bakbakMark marmurPeter libbyR preston masonSamuelcr sherrattElliota brintonMichael szarekAishwarya krishnarajDeepakl bhattNabil abadir

Bivalirudin Crowned as Better Anticoagulant for Primary PCI in STEMI

BRIGHT-4 trial hands the drug a 'clear, unambiguous win' against heparin

New yorkUnited statesFrance generalUnited kingdomKastratia bivalirudinAdnan kastratiPhilippe gabriel stegDeutsches herzzentrumAmerican heart associationAcademic research consortiumIcahn school of medicine at mount sinaiBleeding academic research consortiumGregg stoneIcahn schoolMount sinaiHeparin trial

BRIGHT-4: Large, Clean Trial Clarifies Bivalirudin Benefits in STEMI

Experts say it’s likely too late for cath labs to stomach a bolus plus infusion, having turned back to heparin once and for all.

New yorkUnited statesFrance generalAdnan kastratiYaling hanPhilippe gabriel stegDeutsches herzzentrumAmerican heart associationGeneral hospitalNorthern theater commandGregg stoneIcahn schoolMount sinaiRod stablesLiverpool heartChest hospital